# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-25-276161
Filing Date
2025-11-12
Accepted
2025-11-12 08:45:28
Documents
27
Period of Report
2025-11-12
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | alks-20251112.htm iXBRL | 8-K | 62680
2 | EX-99.1 | alks-ex99_1.htm | EX-99.1 | 43278
3 | EX-99.2 | alks-ex99_2.htm | EX-99.2 | 16922
4 | GRAPHIC | alks-ex99_2s1.jpg | GRAPHIC | 259722
5 | GRAPHIC | alks-ex99_2s2.jpg | GRAPHIC | 567133
6 | GRAPHIC | alks-ex99_2s3.jpg | GRAPHIC | 241237
7 | GRAPHIC | alks-ex99_2s4.jpg | GRAPHIC | 324637
8 | GRAPHIC | alks-ex99_2s5.jpg | GRAPHIC | 329043
9 | GRAPHIC | alks-ex99_2s6.jpg | GRAPHIC | 438775
10 | GRAPHIC | alks-ex99_2s7.jpg | GRAPHIC | 346166
11 | GRAPHIC | alks-ex99_2s8.jpg | GRAPHIC | 317704
12 | GRAPHIC | alks-ex99_2s9.jpg | GRAPHIC | 317425
13 | GRAPHIC | alks-ex99_2s10.jpg | GRAPHIC | 367375
14 | GRAPHIC | alks-ex99_2s11.jpg | GRAPHIC | 404774
15 | GRAPHIC | alks-ex99_2s12.jpg | GRAPHIC | 267344
16 | GRAPHIC | alks-ex99_2s13.jpg | GRAPHIC | 324602
17 | GRAPHIC | alks-ex99_2s14.jpg | GRAPHIC | 333530
18 | GRAPHIC | alks-ex99_2s15.jpg | GRAPHIC | 134224
| Complete submission text file | 0001193125-25-276161.txt |  | 7100682

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
19 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | alks-20251112.xsd | EX-101.SCH | 30799
30 | EXTRACTED XBRL INSTANCE DOCUMENT | alks-20251112_htm.xml | XML | 4683

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 251469421
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)